{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:20:02Z","timestamp":1793262002289,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jpeds.2015.02.043","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T22:12:38Z","timestamp":1428271958000},"page":"1377-1384.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia"],"prefix":"10.1016","volume":"166","author":[{"given":"D. Meeike","family":"Kusters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Caceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Cuffie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter O.","family":"Kwiterovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Massaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"McCrindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Musliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Triscari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.P.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2015.02.043_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MOL.0b013e3283587522","article-title":"Familial hypercholesterolemia in children and adolescents","volume":"23","author":"McCrindle","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","article-title":"A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia","volume":"168","author":"Marks","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpeds.2015.02.043_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2008-1349","article-title":"Lipid screening and cardiovascular health in childhood","volume":"122","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"issue":"Suppl 5","key":"10.1016\/j.jpeds.2015.02.043_bib4","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.02.043_bib5","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpeds.2015.02.043_bib7","first-page":"415","article-title":"Ezetimibe therapy: mechanism of action and clinical update","volume":"8","author":"Phan","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jpeds.2015.02.043_bib8","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.0000018744.58460.62","article-title":"Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia","volume":"105","author":"Gagne","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2015.02.043_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ahj.2004.03.052","article-title":"Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin","volume":"148","author":"Stein","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jpeds.2015.02.043_bib10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2015.02.043_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacc.2008.09.002","article-title":"Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia","volume":"52","author":"van der Graaf","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/clp.10.49","article-title":"Update on the efficacy and safety of combination ezetimibe plus statin therapy","volume":"5","author":"Toth","year":"2010","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1515\/JPEM.2009.22.6.487","article-title":"Ezetimibe as monotherapy in the treatment of hypercholesterolemia in children and adolescents","volume":"22","author":"Yeste","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2015.02.043_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anpedi.2011.11.007","article-title":"Use of ezetimibe in the treatment of familial hypercholesterolemia in children and adolescents","volume":"77","author":"Araujo","year":"2012","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.jpeds.2015.02.043_bib15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jpeds.2008.12.044","article-title":"Ezetimibe treatment of pediatric patients with hypercholesterolemia","volume":"154","author":"Clauss","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.02.043_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.2005-2374","article-title":"Dietary recommendations for children and adolescents: a guide for practitioners","volume":"117","author":"Gidding","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2015.02.043_bib17","first-page":"134","article-title":"Longitudinal data analysis of continuous and discrete responses for pre-post designs","volume":"62","author":"Liang","year":"2000","journal-title":"Sankhya Ser B"},{"key":"10.1016\/j.jpeds.2015.02.043_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.jpeds.2015.02.043_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S1047951113000528","article-title":"Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades","volume":"24","author":"Elis","year":"2014","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jpeds.2015.02.043_bib20","first-page":"P52","article-title":"Multiple-dose safety and pharmacokinetics of ezetimibe in adolescent children (abstr)","volume":"69","author":"Kosoglou","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2015.02.043_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00003088-200544050-00002","article-title":"Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions","volume":"44","author":"Kosoglou","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2015.02.043_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2796.2008.02062.x","article-title":"Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials","volume":"265","author":"Pandor","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpeds.2015.02.043_bib23","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2015.02.043_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4065\/79.5.620","article-title":"Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial","volume":"79","author":"Goldberg","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpeds.2015.02.043_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1463-1326.2009.01152.x","article-title":"Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither","volume":"12","author":"Conard","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jpeds.2015.02.043_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3132\/dvdr.2006.020","article-title":"Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome","volume":"3","author":"Denke","year":"2006","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jpeds.2015.02.043_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1463-1326.2011.01383.x","article-title":"Lipid-altering efficacy and safety profile of combination therapy with ezetimibe\/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials","volume":"13","author":"Leiter","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jpeds.2015.02.043_bib28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1185\/030079904X2321","article-title":"Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome","volume":"20","author":"Simons","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpeds.2015.02.043_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijcard.2005.01.022","article-title":"Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease","volume":"102","author":"Farnier","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.amjcard.2008.09.076","article-title":"Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease","volume":"102","author":"Leiter","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacl.2007.07.003","article-title":"Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterotemia","volume":"1","author":"Stein","year":"2007","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2147\/VHRM.S13496","article-title":"Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia","volume":"6","author":"Hamilton-Craig","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jpeds.2015.02.043_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1185\/030079905X28872","article-title":"Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias","volume":"21","author":"Wierzbicki","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpeds.2015.02.043_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11883-012-0296-2","article-title":"The rationale for initiating treatment of hypercholesterolemia in young adulthood","volume":"15","author":"Steinberg","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jpeds.2015.02.043_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","article-title":"Statin treatment of children with familial hypercholesterolemia\u2014trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?","volume":"226","author":"Vuorio","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpeds.2015.02.043_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/archdischild-2011-300081","article-title":"Paediatric screening for hypercholesterolaemia in Europe","volume":"97","author":"Kusters","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2015.02.043_bib38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/clc.22050","article-title":"Universal screening of cholesterol in children","volume":"35","author":"Kwiterovich","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib39","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpeds.2015.02.043_bib40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jacc.2009.10.042","article-title":"Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia","volume":"55","author":"Avis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2015.02.043_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","article-title":"Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial","volume":"142","author":"McCrindle","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2015.02.043_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615001638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347615001638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T17:57:14Z","timestamp":1537725434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347615001638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0022347615001638"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.02.043","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2015.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}